AzTrials
AzTrials

Pediatric Emergency MedicineNCT05557331

Effectiveness of a Mobile App in Reducing Therapeutic TAT in an Emergency Department

A study testing PIMPmyHospital (mobile app) in people with Pediatric Emergency Medicine and Therapeutic Turnaround Time, run by Pediatric Clinical Research Platform at 2 sites in Switzerland.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study is a single center, non-equivalent comparison group, pre-post study in a tertiary pediatric emergency department in Switzerland. the study will compare the control and experimental groups on outcome measures before (12-month period) and after (6-month period) the intervention consisting of the… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
What is being tested?
PIMPmyHospital (mobile app)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
2 sitesSwitzerland
Study dates
1 Mar 2025to 1 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Any postgraduate residents pursuing a <6 years residency in pediatrics.
  • Any pediatric emergency medicine fellows.
  • To be registered nurses from the pediatric emergency department.
  • Participation agreement.

Who cannot join

  • none

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Johan N Siebert, MD contact

+41 79 553 40 72

Johan.Siebert@hcuge.ch

Frederic Ehrler, PhD contact

Frederic.Ehrler@hcuge.ch

Switzerland2 sites, 2 recruiting
  • Geneva Children's Hospital, Geneva University Hospitals

    Geneva, Canton of Geneva, 1205

    Alain Gervaix, Prof, +41 (0)22 372 45 55, Alain.Gervaix@hcuge.ch

    Johan Siebert, MD, +41 (0)22 372 45 55, Johan.Siebert@hcuge.ch

    Recruiting
  • Geneva Children's Hospital, Geneva University Hospitals

    Geneva, Canton of Geneva, 1205

    Johan N Siebert, MD, +41 (0)22 372 45 55, Johan.Siebert@hcuge.ch

    Frederic Ehrler, PhD, +41 (0)22 372 86 97, Frederic.Ehrler@hcuge.ch

    Recruiting

Other trials in Switzerland

About this study

Official title: Effectiveness of a Mobile App (PIMPmyHospital) in Reducing Therapeutic Turnaround Times in an Emergency Department: Protocol for a Pre-Post Intervention Study

This study is a single center, non-equivalent comparison group, pre-post study in a tertiary pediatric emergency department in Switzerland. the study will compare the control and experimental groups on outcome measures before (12-month period) and after (6-month period) the intervention consisting of the implementation and use of the evidence-based mobile app-the ''Patients In My Pocket in my Hospital'' (PIMPmyHospital) app.

The primary outcome will be the mean elapsed time in minutes between the delivery of lab results and the emergency department caregivers accessing them before (i.e., on the institutional electronic medical records) and after the implementation of the app (i.e, directly on the app).

Read the detailed description

The study objective is to evaluate whether the use of the PIMPmyHospital app alters emergency departments (ED) physicians and nurses' temporal efficiency to learn about laboratory results more quickly while actively working in an ED. Temporal efficiency will be assessed by measuring the time between the release of the laboratory results in the clinical information system and their acknowledgement by these clinicians. Information regarding the app has been published previously (doi.org/10.3390/jpm12030428).

The investigators will conduct an 18-month, single center, non-equivalent comparison group, pre-post study. The study will compare the control and experimental groups on outcome measures before (12-month period) and after (6-month period) the intervention consisting of the use of the app. The study will take place in the pediatric ED of a tertiary referral and major trauma hospital in Switzerland, with an annual volume of 35,000 visits.

Eligible participants will be postgraduate residents pursuing a <6-year residency in pediatrics, pediatric emergency medicine fellows, and registered nurses from the pediatric ED (aged > 18 years). Written informed consent will be obtained from each participant in the interventional group after full information disclosure prior to study participation.

Before the implementation of the app, electronic medical records (EMR)-based data from the past 12 months will be collected retrospectively. These data include the times (i.e., HH:MM:SS) that results issued by the central laboratory were available on the institutional's EMR, as well as the times at which these results were accessed by caregivers via conventional computerized workstations. (ii) After the implementation of the app, data will be collected prospectively over a 6-month period of use. This will include the times (HH:MM:SS) when the results issued by the central laboratory are made available on caregivers' mobile app and access times, as well as concurrent or preferred access times on the conventional computerized workstations should this occur. Individual acceptance of the app on the first day (a priori), at 1 week, and then on the last day of the intervention (6 months) will be evaluated through the Unified Theory of Acceptance, and Use of Technology (UTAUT). Usability of the app will be measured by the System Usability Scale (SUS).

The primary outcome will be the mean elapsed time in minutes between the delivery of the lab results and the caregiver accessing them, both before and after the implementation of the app.

Being tested
PIMPmyHospital (mobile app)
Keywords
Information technologies, Mobile Applications, Laboratory Result Delivery, Therapeutic turnaround time, Information Storage and Retrieval, Hospital Communication Systems, Pediatric Emergency Medicine, Emergency Department
Medical subject headings
Emergencies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PIMPmyHospital (mobile app)Device

    After the implementation of the app, data will be collected prospectively over a 6-month period of use. This will include the times (HH:MM:SS) when the results issued by the central laboratory are made available on caregivers' mobile app and access times (as well as concurrent or preferred access times on the conventional computerized workstations should this occur).

Study groups in NCT05557331
Study groupRoleWhat they receive
Pre-intervention (no app)No interventionParticipants before (12-month retrospective period) the implementation of the app in the emergency department.
Post-intervention (PIMPmyHospital app)Active comparatorParticipants that will use the mobile heath PIMPmyHospital app during the prospective 6-month period after the implementation of the app in the emergency department.
Receives: Device: PIMPmyHospital (mobile app)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to lab results review

    The mean elapsed time in minutes between the delivery of the lab results and the caregiver accessing them, both before and after the implementation of the app.

    Measured: 1 year (retrospective) and 6 months (prospective)

Secondary outcomes (4)
  1. Unified Theory of Acceptance, and Use of Technology (UTAUT)

    Acceptance of the app by participants on the first day (a priori) and then at 1 week and on the last day of the intervention will be evaluated through the Unified Theory of Acceptance, and Use of Technology (UTAUT) questionnaire.

    The UTAUT is a 8-construct, 31-item questionnaire. The items are measure along a 5-point Likert scale, which ranges from "strongly agree" (1) to "strongly disagree" (5).

    Measured: 6 months

  2. System Usability Scale (SUS)

    Usability of the app will be measured by the System Usability Scale (SUS).

    The SUS comprises a 10-item questionnaire with 5 response options for each item based on their level of agreement, ranging from 1 (strongly disagree) to 5 (strongly agree). For odd-numbered statements (the positively worded items), the score contribution is equal to the scale position minus 1. For even-numbered statements (the negatively worded items), the score contribution is equal to 5 minus the scale position. Each score contribution falls within the range of 0 to 4. The participants' scores for each item are then added up together and multiplied by 2.5 to convert the original scores of 0 to 40 to 0 to 100. The higher the score, the better the usability.

    Measured: 6 months

  3. Emergency department length of stay

    The emergency department length of stay per patient measured from the point when patients are triaged in the ED to when discharged from the ED, defined as patients leaving the ED whether admitted to the intensive care unit or ward, transferred to another hospital for admission, discharged home, or those who left without being seen.

    Measured: 1 year (retrospective) and 6 months (prospective)

  4. Cognitive alerts

    Whether specific alerts, such as a flashing icon or sound for reported pathological values of laboratory results on the mobile app have an impact on the results.

    This will be measured using a questionnaire that each participant using the app will answer on a 5-point Likert scale, ranging from "strongly agree" (1) to "strongly disagree" (5).

    Measured: 1 year (retrospective) and 6 months (prospective)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2022
  2. Study start1 Mar 2025
  3. Primary completion30 Nov 2025 (estimated)
  4. Study completion1 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Sequential
Model description
A single center, non-equivalent comparison group, pre-post study.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
18 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05557331
Sponsor's protocol ID
PIMPmyHospital pre-post study
Status last verified
Aug 2025
First submitted
18 Sep 2022
Last updated
19 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual Participant Data will be deidentified and the study investigators will house the data locally on REDCap hosted on secured servers at the Geneva University Hospitals. The datasets used or analyzed during the current trial will be available from the corresponding author upon reasonable request, recognizing that these data will only provide results for the current pre-post study and not for future trials that would follow. Only deidentified/anonymized data will be shared.

Publications

  • Ehrler F, Tuor C, Rey R, Siebert JN. A Mobile App to Improve Patient Management in Emergency Departments: Caregiver Needs Analysis, Design and Early Technology Acceptance Assessment. Stud Health Technol Inform. 2021 Oct 27;285:233-238. doi: 10.3233/SHTI210605.

    PubMed 34734879
  • Ehrler F, Tuor C, Trompier R, Berger A, Ramusi M, Rey R, Siebert JN. Effectiveness of a Mobile App in Reducing Therapeutic Turnaround Time and Facilitating Communication between Caregivers in a Pediatric Emergency Department: A Randomized Controlled Pilot Trial. J Pers Med. 2022 Mar 9;12(3):428. doi: 10.3390/jpm12030428.

    PubMed 35330427
  • Ehrler F, Tuor C, Rey R, Trompier R, Berger A, Ramusi M, Courvoisier DS, Siebert JN. Effectiveness of a Mobile App (PIMPmyHospital) in Reducing Therapeutic Turnaround Times in an Emergency Department: Protocol for a Pre- and Posttest Study. JMIR Res Protoc. 2023 May 3;12:e43695. doi: 10.2196/43695.

    PubMed 37133909

Questions about this trial

What is this clinical trial studying?

A study testing PIMPmyHospital (mobile app) in people with Pediatric Emergency Medicine and Therapeutic Turnaround Time, run by Pediatric Clinical Research Platform at 2 sites in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Johan N Siebert, MD (+41 79 553 40 72, Johan.Siebert@hcuge.ch), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to lab results review (time frame: 1 year (retrospective) and 6 months (prospective)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05557331, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in